Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of an ACYW135 meningococcal conjugate vaccine in healthy infants aged 3 to 5 months
CTR20260763Phase 3Active
- Sponsor
- Sino Biopharmaceutical Limited
- Start
- Mar 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal disease, meningococcal meningitis, sponsored by Sino Biopharmaceutical Limited. Started Mar 2026; status: active.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on CTR20260763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260763.